Clinical Trials in Alabama

Alabama is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Alabama and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 192 actively recruiting studies with Alabama sites out of 192 registered in total. The busiest research areas in Alabama are Multiple Myeloma, Sickle Cell Disease, Obesity. Leading sponsors running trials in the state include University of Alabama at Birmingham, AstraZeneca, Novartis Pharmaceuticals. By stage, Alabama trials break down as Phase 1 (29), Phase 2 (58), Phase 3 (53), Phase 4 (11).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Frequently Asked Questions — Clinical Trials in Alabama